Fukuyama Congenital Muscular Dystrophy (FCMD) is a severe genetic disorder primarily affecting muscle function and development, leading to muscle weakness and brain and eye abnormalities. It is caused by mutations in the FKTN gene, which plays a crucial role in maintaining muscle cell integrity. The condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
To diagnose FCMD and identify the specific FKTN gene mutations, a genetic test is available at DNA Labs UAE. This test involves analyzing the patient's DNA to search for mutations in the FKTN gene that are known to cause the condition. It is a critical step for confirming the diagnosis, understanding the disease's progression, and informing family planning decisions.
The cost of the FKTN Gene Fukuyama Congenital Muscular Dystrophy Genetic Test at DNA Labs UAE is 4400 AED. This test is a valuable resource for families affected by or at risk of FCMD, providing them with essential information for managing the condition and planning for the future.
The "ROBO3 Gene Gaze Palsy Horizontal with Progressive Scoliosis Genetic Test" is a specialized diagnostic assessment available at DNA Labs UAE, designed to detect mutations in the ROBO3 gene. These mutations are linked to a rare neurological disorder characterized by horizontal gaze palsy and progressive scoliosis, a condition where patients are unable to move their eyes horizontally and develop a sideways curvature of the spine that worsens over time. This genetic test plays a crucial role in the early detection and management of the disorder, enabling healthcare professionals to devise appropriate treatment plans and offer genetic counseling to affected families. The cost of the test is 4400 AED, reflecting the advanced technology and expertise required to accurately identify the genetic anomaly associated with this condition.
The "KCNMA1 Gene Generalized Epilepsy and Paroxysmal Dyskinesia Genetic Test" is a specialized diagnostic examination offered by DNA Labs UAE, designed to identify mutations in the KCNMA1 gene. Mutations in this gene are known to be associated with a range of neurological conditions, including generalized epilepsy and paroxysmal dyskinesia. These disorders are characterized by recurrent seizures and involuntary movements, respectively, which can significantly impact an individual's quality of life.
This genetic test involves analyzing the patient's DNA to detect abnormalities in the KCNMA1 gene, providing crucial information for accurate diagnosis and tailored treatment planning. It is particularly beneficial for individuals who exhibit symptoms of these conditions or have a family history of related neurological disorders.
The cost of the test is 4400 AED, reflecting the advanced technology and expertise required to perform the analysis. Conducted at DNA Labs UAE, a leading facility in genetic testing, patients can expect high-quality service and reliable results. This test represents a significant step forward in the personalized treatment of neurological conditions, offering hope to many individuals and families affected by these challenging disorders.
The SCN1B gene is associated with a condition known as Generalized Epilepsy with Febrile Seizures Plus Type 1 (GEFS+1). This genetic disorder is characterized by a broad spectrum of seizure types that can vary significantly in severity among affected individuals. The SCN1B gene plays a crucial role in the functioning of sodium channels in the brain, which are essential for the proper transmission of electrical signals. Mutations in the SCN1B gene can disrupt these channels, leading to the development of epilepsy and related seizure disorders.
To diagnose this condition and understand its genetic basis, a specialized genetic test targeting the SCN1B gene can be conducted. At DNA Labs UAE, this test is available for individuals who may be at risk of GEFS+1 due to their family history or for those who exhibit symptoms suggestive of this condition. The test involves analyzing the DNA to identify mutations in the SCN1B gene that are known to be associated with the disorder.
The cost of the SCN1B Gene Generalized Epilepsy with Febrile Seizures Plus Type 1 Genetic Test at DNA Labs UAE is 4400 AED. The test provides valuable information that can aid in the diagnosis and management of the condition, enabling healthcare providers to tailor treatment plans more effectively for those affected. Additionally, understanding the genetic underpinnings of GEFS+1 can offer insights into potential risks for family members and inform decisions regarding genetic counseling.
The SCN1A gene Generalized Epilepsy with Febrile Seizures Plus Type 2 (GEFS+2) genetic test is a specialized diagnostic tool available at DNA Labs UAE, designed to detect mutations in the SCN1A gene. This gene plays a critical role in the functioning of brain cells by coding for a subunit of the sodium channel, which is essential for the transmission of electrical signals in the nervous system. Mutations in the SCN1A gene are associated with various epilepsy syndromes, including GEFS+2, which is characterized by a spectrum of seizure types that range from mild febrile seizures to more severe forms of epilepsy.
The test is particularly important for individuals who have a family history of GEFS+2 or exhibit symptoms suggestive of this condition. By analyzing a sample of the patient's DNA, the test can confirm the presence of mutations in the SCN1A gene, providing valuable information for diagnosis, management, and treatment planning. This can also offer insights into the risk of epilepsy in family members and the likelihood of passing the condition to offspring.
The cost of the SCN1A gene Generalized Epilepsy with Febrile Seizures Plus Type 2 genetic test at DNA Labs UAE is 4400 AED. Given the complexity of the test and the specific expertise required to interpret the results, it represents a critical investment in the accurate diagnosis and tailored management of epilepsy syndromes associated with SCN1A mutations.
The GABRG2 Gene Generalized Epilepsy with Febrile Seizures Plus Type 3 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the GABRG2 gene. This gene plays a crucial role in the functioning of GABA receptors, which are integral for inhibiting signals in the brain. Mutations in the GABRG2 gene are associated with Generalized Epilepsy with Febrile Seizures Plus (GEFS+), a condition characterized by febrile seizures that often extend beyond the typical age range and may evolve into other types of seizures or epilepsy.
The test is particularly important for individuals with a family history of GEFS+ or related seizure disorders, as it can provide vital information for accurate diagnosis, management, and treatment planning. Conducted in the state-of-the-art facilities of DNA Labs UAE, this genetic test ensures high accuracy and reliability. The cost of the test is 4400 AED, reflecting the comprehensive nature of the analysis and the detailed insights it offers into the genetic underpinnings of epilepsy and related seizure disorders.
The SCN9A Gene Generalized Epilepsy with Febrile Seizures Plus Type 7 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE. Priced at 4400 AED, this test is designed to identify mutations in the SCN9A gene, which have been linked to the development of Generalized Epilepsy with Febrile Seizures Plus (GEFS+) Type 7, a complex and rare epileptic disorder. GEFS+ Type 7 is characterized by a broad spectrum of seizure types that usually begin in infancy or early childhood and may persist into adulthood. These seizures are often triggered by fever but can occur without it as the individual ages.
The SCN9A gene plays a critical role in the functioning of sodium channels in the brain, which are essential for the transmission of electrical signals in the nervous system. Mutations in this gene can disrupt the normal flow of electrical signals, leading to the development of seizures.
The test involves a detailed analysis of the individual's DNA to detect any abnormalities or mutations in the SCN9A gene that might be responsible for the condition. This genetic testing is crucial for the accurate diagnosis of GEFS+ Type 7, allowing for personalized treatment plans that can significantly improve the quality of life for affected individuals.
Administered by the experienced professionals at DNA Labs UAE, the test is conducted with the utmost precision and care, ensuring reliable results for patients and their families.
The STX1B gene generalized epilepsy with febrile seizures plus type 9 genetic test is a specialized diagnostic tool used to identify mutations in the STX1B gene, which have been associated with the development of generalized epilepsy with febrile seizures plus (GEFS+) type 9. This condition is a form of epilepsy that typically manifests in childhood and is characterized by the occurrence of febrile seizures, which are seizures accompanied by fever, as well as a spectrum of other seizure types as the individual ages. The identification of a mutation in the STX1B gene can help in confirming a diagnosis, guiding treatment options, and providing information on the risk of inheritance for family members.
The test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The cost of the test is 4400 AED, which reflects the comprehensive analysis and the specialized technology required to accurately identify mutations in the STX1B gene. By opting for this test, patients and their families can gain valuable insights into the genetic basis of the condition, enabling more personalized and effective management of the disorder.
The CHRNA2 Gene Epilepsy Nocturnal Frontal Lobe Type 4 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE. This test is designed to identify mutations in the CHRNA2 gene, which have been linked to epilepsy nocturnal frontal lobe type 4 (ENFL4). ENFL4 is a rare form of epilepsy characterized by nocturnal seizures with frontal lobe origin, affecting individuals during sleep. The CHRNA2 gene plays a crucial role in the proper functioning of neuronal nicotinic acetylcholine receptors, which are essential for normal neurological activity. Mutations in this gene can disrupt normal brain activity, leading to the development of epilepsy.
The test is conducted through a detailed analysis of the patient's DNA, extracted from a blood sample, to detect any genetic anomalies in the CHRNA2 gene. This genetic testing is pivotal for individuals with a family history of ENFL4 or those exhibiting symptoms, as it provides a definitive diagnosis, enabling targeted treatment and management of the condition.
The cost of the CHRNA2 Gene Epilepsy Nocturnal Frontal Lobe Type 4 Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive nature of the test, covering the expenses of the genetic analysis, the expertise of the medical professionals involved, and the use of advanced laboratory technology to ensure accurate results. Undergoing this test at DNA Labs UAE offers patients access to state-of-the-art genetic testing services, with reliable results that can significantly impact the management and understanding of epilepsy nocturnal frontal lobe type 4.
The SCARB2 Gene Epilepsy Progressive Myoclonic Type 4 with or without Renal Failure Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the SCARB2 gene. This gene is crucial for understanding a rare form of epilepsy known as Progressive Myoclonic Epilepsy Type 4 (EPM4), which may also be associated with renal failure in some cases. The condition is characterized by progressive muscle jerks, seizures, and, in some instances, kidney dysfunction. Identifying mutations in the SCARB2 gene can help in confirming the diagnosis, allowing for a better-informed approach to treatment and management of the condition.
The test is priced at 4400 AED and involves analyzing the patient's DNA to detect any genetic abnormalities that could be responsible for the condition. By opting for this test at DNA Labs UAE, patients and healthcare providers can gain crucial insights into the genetic underpinnings of the disease, paving the way for personalized treatment plans and interventions. This genetic test is an essential tool for those suspected of having this form of epilepsy, offering hope for improved quality of life through targeted therapies and management strategies.
